Bioiberica closed 2009 with a turnover of $152 million and significant growth compared to the previous year. These results indicate that the company is on the right track and heading for a promising future.
This endorses the company's commitment and responsibility to strengthen and consolidate its ethical corporate governance based on the strictest legal and regulatory standards.